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J Appl Physiol 107: 880–886, 2009. First published June 25, 2009;
doi:10.1152/japplphysiol.00291.2009.—Age-related loss in muscle
mass and strength impairs daily life function in the elderly. However,
it remains unknown whether tendon properties also deteriorate with
age. Cross-linking of collagen molecules provides structural integrity
to the tendon fibrils and has been shown to change with age in animals
but has never been examined in humans in vivo. In this study, we
examined the mechanical properties and pyridinoline and pentosidine
cross-link and collagen concentrations of the patellar tendon in vivo in
old (OM) and young men (YM). Seven OM (67  3 years, 86  10
kg) and 10 YM (27  2 years, 81  8 kg) with a similar physical
activity level (OM 5 6 h/wk, YM 5 2 h/wk) were examined. MRI
was used to assess whole tendon dimensions. Tendon mechanical
properties were assessed with the use of simultaneous force and
ultrasonographic measurements during ramped isometric contrac-
tions. Percutaneous tendon biopsies were taken and analyzed for
hydroxylysyl pyridinoline (HP), lysyl pyridinoline (LP), pentosidine,
and collagen concentrations. We found no significant differences in
the dimensions or mechanical properties of the tendon between OM
and YM. Collagen concentrations were lower in OM than in YM
(0.49  0.27 vs. 0.73  0.14 mg/mg dry wt; P  0.05). HP
concentrations were higher in OM than in YM (898  172 vs. 645 
183 mmol/mol; P 0.05). LP concentrations were higher in OM than in
YM (49  38 vs. 16  8 mmol/mol; P  0.01), and pentosidine
concentrations were higher in OM than in YM (73  13 vs. 11  2
mmol/mol; P 0.01). These cross-sectional data raise the possibility that
age may not appreciably influence the dimensions or mechanical prop-
erties of the human patellar tendon in vivo. Collagen concentration was
reduced, whereas both enzymatic and nonenzymatic cross-linking of
concentration was elevated in OM vs. in YM, which may be a mechanism
to maintain the mechanical properties of tendon with aging.
tendon dimension; tendon mechanical properties; aging; collagen;
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FORCE GENERATED BY MUSCLE is transferred to bones via tendons
to produce movement. However, tendons are not entirely
inextensible, but exhibit elastic and time-dependant properties
that serve to influence the overall function of the muscle-
tendon complex (3, 13, 17, 29, 58). Tendons have traditionally
been considered relatively inert structures, but several recent
reports have demonstrated that human tendons respond directly
to physical activity by increased metabolic activity (15, 35, 42)
and increased collagen synthesis (50, 51). Furthermore,
strength training and habitual loading of tendons appear to be
associated with increased tendon size (6, 21, 46), confirming
that the aforementioned response to elevated loading results in
a net increase of tendon tissue. These recent findings show that
tendons respond and adapt to their specific loading history.
Aging is associated with a decline in muscle mass, strength,
and physical function (66). However, although tendon proper-
ties influence the overall function of the muscle-tendon com-
plex (58, 67), there is a relative lack of human data that
describe possible age-associated changes in mechanical prop-
erties of tendon. Animal data show that aging yields a stronger
and stiffer tendon (34, 69, 83), a weaker and more compliant
tendon (27, 90, 91), or leaves the tendon unchanged (39); thus
these data are inconclusive. In contrast, data on isolated human
cadaver tendon suggest that the aging process largely leaves
the mechanical properties unaltered (31, 40, 41). Despite the
development of ultrasonography-based methods to evaluate
human tendon properties in vivo (33, 37, 53), the effect of
aging on the mechanical properties of human tendon in vivo
remains elusive. Tendon strain in humans has been shown to
decrease (47–49) or increase (43, 52, 61, 63, 70) with aging.
Yet others have shown that aging leaves the mechanical prop-
erties of the patellar tendon unchanged (18). Thus the picture is
incoherent, which may partly be related to methodological and
design differences, the physical activity level of the sample
population, and the type of tendon tested, i.e., the tendon-
aponeurosis complex or the free tendon alone.
In tendon, the trivalent intermolecular pyridinoline cross-
links [primarily hydroxylysyl pyridinoline (HP) and lysyl pyr-
idinoline (LP)] stabilize the fibrillar structure of collagen and
thus contribute to the mechanical properties of the tendon (7, 9,
12). These cross-links are formed from enzymatically derived
covalent immature cross-links, which undergo a spontaneous
conversion into more mature trivalent cross-links with collagen
maturation (7). The slow turnover of mature collagen allows
further cross-linking via the adventitious nonenzymatic reac-
tions of glucose with the lysyl and arginine amino acid residues
in the collagen triple helix as a true aging process (7, 59, 62).
This nonenzymatic process results in the accumulation of
advanced glycation end products (AGE) in tendon tissue. The
most widely studied AGE is pentosidine. AGE accumulation is
known to accelerate with aging and diabetes (16, 28, 62) and is
believed to yield a stiffer and more load-resistant tendon (78,
79). It has been shown that AGE cross-link density in collag-
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enous tissues (19, 38, 81, 86) and in human tendons (11, 84) is
markedly higher in older than in younger individuals, and there
are only sparse human data on mature cross-link density of
tendon and how these are influenced by aging (11). However,
recent reports of an age-associated reduction in human tendon
stiffness in vivo (43, 52, 61, 63, 70) in conjunction with the
notion of simultaneously elevated cross-link density and AGE
accumulation are difficult to reconcile. To the best of our
knowledge, there are currently no human studies examining
collagen cross-linking and mechanical properties of the patellar
tendon in vivo in old and young men. Therefore, the purpose of
this study was to examine both the mechanical properties of
human patellar tendon in vivo and collagen cross-link compo-
sition in old (OM) and young men (YM) subjects.
MATERIALS AND METHODS
Subjects. Seven OM (67  3 years, 86  10 kg) and 10 YM (27 
2 years, 81  8 kg) with similar activity levels volunteered for the
study (Table 1). With the use of a standardized form, participants were
interviewed regarding how many hours per week they were perform-
ing organized sport or exercise on a regular basis (OM: 5  6 h/wk,
YM: 5  2 h/wk). There were no differences in physical character-
istics between OM and YM. All were healthy, did not take prescrip-
tion medicine, and had no overt signs or symptoms of diabetes. In
addition, the subjects had no known knee or tendon pathology. The
study complied with the Declaration of Helsinki and was approved by
the local ethics committee. All subjects gave their informed consent
before the experiments.
Muscle and tendon dimensions. The anatomic cross-sectional area
(CSA) of the quadriceps femoris muscle was measured 20 cm prox-
imal to the tibia plateau (mid-thigh level) by magnetic resonance
imaging (MRI) (General Electric, Sigma Horizon LX 1.5-Tesla, T1
weighted SE) using a lower extremity coil. The images were obtained
using the following parameters: TR/TE  500/14 ms, field of view
(FOV)  18, matrix  512  512, and slice thickness  6 mm (21,
46). Subsequently, the lean muscle mass of the quadriceps muscle
(subcutaneous and intermuscular noncontractile tissues were excluded
from the measurement) was manually outlined using the software
program Osiris 4.19 (http://www.sim.hcuge.ch/osiris/). The mean
value of three measurements of the same image was used for analysis.
Patellar tendon CSA and length were determined with the use of MRI
(General Electric, Sigma Horizon LX, 1.5-Tesla, T1 weighted SE)
(21, 46). Patellar tendon CSA was determined by axial plane MRI
using the following parameters: TR/TE  400/14 ms, FOV  20,
matrix 256 256, slice thickness 5.0 mm, and spacing 0 mm.
The axial scans were performed perpendicular to the patellar tendon.
As described in detail previously, the tendon CSA was measured
1) just distal to the patellar insertion, 2) just proximal to the tibia
insertion, and 3) midway between these two sites (21, 46). The
patellar tendon length was determined from sagittal plane MRI using
the following parameters: TR 500, echo time (ET) 3 (TE: 12.4
ms), FOV  16, matrix  256  192, slice thickness  4.0 mm, and
no spacing. The patellar tendon length was obtained by measuring the
distance from the dorsal insertion at the patella apex to the dorsal
insertion on the tibia. Patellar tendon CSA and length were manually
outlined using the software program Osiris 4.19 (http://www.sim.
hcuge.ch/osiris/). The color intensity of each image was adjusted using
the National Institutes of Health color scale mode of the software. Tendon
CSA and length were measured using the grayscale image display. The
average tendon CSA was calculated from the three levels (proximal, mid,
and distal CSA) and used for analysis. The typical error percent of
repeated measures of site-specific tendon CSA was 2–2.5% (21).
Mechanical properties of tendon. The details of the measurement,
including the reliability of the method in our laboratory, has been
reported previously (37). The within-day correlation coefficient and
typical error percent results for repeated measures were 0.95 and 9.9%
for tendon stiffness, 0.97 and 5.5% for tendon strain, and 0.94 and
9.4% for Young’s modulus. Subjects performed a 5-min warm-up on
a stationary bike to secure proper preconditioning of the tendon before
testing. Thereafter, the subjects were seated in a custom-made rigid
chair with both hips and knees flexed to an angle of 90°. A leg cuff,
which was connected to a strain gauge (Bofors KRG-4, Bofors,
Sweden) through a rigid steel rod perpendicular to the lower leg, was
mounted on the leg just above the medial malleolus. An ultrasound
probe (7.5 MHz, linear array B-mode; Sonoline Sienna, Siemens,
Erlangen, Germany) was fitted into a custom-made rigid cast that was
secured to the skin above the patellar tendon in the sagittal plane. The
ultrasound probe and cast were positioned so that the patella, the
patellar tendon, and the tibia were all visible within the viewing field
throughout the ramped contractions (Fig. 1).
The ultrasound S-VHS video images obtained during the ramp
trials were sampled at 50 Hz on a personal computer using frame-by-
frame capturing software (Matrox Marvel G400-TV, Dorval, Quebec,
Canada). Force was sampled on two separate personal computers at 50
Hz via a 12-bit analog-to-digital converter (dt2810A; Data Transla-
tion). The two computers were interconnected to permit synchronous
sampling of all data using a custom-built trigger device (14). The
subjects performed four to five slow isometric knee extensions ramps
by applying gradually increasing force until maximum over a 10-s
period during which patellar tendon displacement and knee extension
force were measured simultaneously. Each ramp was separated by a
2-min rest period. All measurements were performed on one side,
randomized to either the right or left knee. During the ramp contrac-
tions, force was sampled at 50 Hz and low-pass filtered at a 1.0-Hz
cutoff frequency using a fourth-order zero-lag Butterworth filter.
Tendon force was calculated by dividing the estimated total knee
extension moment by the internal moment arm, which was estimated
from individually measured femur lengths (87). Tendon stress was
calculated by dividing tendon force with the average of the three
levels (proximal, mid, and distal) of the patellar tendon CSA deter-
mined from MRI. Tendon deformation was defined as the change in
distance between the patellar apex and the tibia (37, 57). Tendon
strain was calculated as the change in length related to the initial
tendon length. Each single force-deformation curve was fitted to a
second- or third-order polynomial fit, which yielded R2  0.98.
Tendon stiffness (force/deformation) and Young’s modulus
(stress/strain) based on common force were calculated in the final
20% of the force-deformation and stress-strain curves, respectively
(57). To compare tendon dimensions between the subjects of various
body size, tendon CSA data were normalized to body weight and
raised to the power of 2/3 (60).
Patellar tendon biopsies. A Bard MAGNUM biopsy instrument
(C.R. Bard, Covington, GA) with a disposable core biopsy needle (14
gauge) was used. After sterilization, the skin was injected with local
anesthetic (1% lidocaine), and a 3- to 5-mm-long incision was created
just distal to the patella apex. The biopsy needle was inserted into the
tendon surface at an 30° angle and fired, securing a tissue sample of
8 mg. Samples were snap-frozen in liquid nitrogen and stored at
80°C. Tendon biopsies were taken from the same side as tendon
mechanical properties assessments were performed. No previous bi-
Table 1. Physical characteristics of OM and YM
OM (n  7) YM (n  10)
Age, years 673 272
Height, cm 1789 1834
Weight, kg 8610 818
Activity level, h/wk 56 52
Values are means  SD. There were no differences in physical character-
istics between old men (OM) and young men (YM).
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opsy had been taken from that site in all subjects. All biopsy samples
were analyzed in an investigator-blinded fashion.
Biochemical analysis. Freeze-dried tendon samples were hydro-
lyzed in 6 M HCl (	108 C, 24 h) and evaporated into dryness and
dissolved in H2O. Hydroxyproline, the collagen-specific amino acid,
was measured spectrophotometrically (23) to quantify collagen pro-
tein (24). HP, LP, and pentosidine were analyzed via a single re-
versed-phase high-performance liquid chromatography (HPLC) run
and detected on the basis of their natural fluorescence (10). At 0–16
min, the wavelength for HP and LP fluorescence was 400 nm for
emission and 295 nm for excitation. The wavelengths were changed at
16–60 min to 328/378 nm to measure pentosidine. For the elution of
the cross-links, a gradient was built up to contain 17% eluent B (75%
acetonitrile with 0.13% heptafluorobutyric anhydride) at 0 min and 25%
eluent B at 30 min. Eluent A was 0.13% heptafluorobutyric anhydride.
Flow rate was 1 ml/min. HP was eluted at 12 min, LP at 13.5 min, and
pentosidine at 23 min. The HPLC system used included Quaternary
Gradient Pump unit, PU-2089 Plus, Intelligent AutosamplerAS-2057
Plus, and Intelligent Fluorescence Detector FP-2020 by Jasco. Data
processing software was Jasco Chrompass. The LiChroCART 125-4
column was from Merck Hitachi. The results for HP, LP, and pentosidine
are given compared with the standards injected at four different concen-
trations in each HPLC run. The intra-assay coefficient of variations based
on duplicates within a run were 2.6%, 3.7%, and 3.9% for HP, LP, and
pentosidine, respectively. The detection limit for HP and LP is 0.4 pmol
and 0.05 pmol for pentosidine.
Data reduction and analysis. The two isometric ramp contractions
that yielded the greatest maximum force were selected for further
analysis. To make group comparisons and thereby account for differ-
ences in magnitude in isometric ramp contraction force, the trials for
all subjects were subsequently analyzed to the lowest common force,
as determined by the weakest subject (3953 N). Mann-Whitney
U-tests were used to examine whether there were differences between
the groups in the measured variables. Spearman rank-order correlation
was used to analyze the strength of relationships between variables. P
0.05 was considered significant. Results are reported as means  SD.
RESULTS
Peak knee extensor moment was lower in OM (154 41 N m)
than in YM (216  62 N m) (P  0.05). Similarly, quadriceps
femoris CSA was lower in OM than in YM (Table 2) (P 0.01).
Tendon dimensions are shown in Table 2. Tendon length did
not differ between YM and OM. Absolute average tendon CSA
did not differ between OM and YM. Similarly, there was no
between group difference in average tendon CSA normalized
for body weight.
Mechanical properties determined at maximal force are
shown in Table 3. Maximal tendon force was lower in OM than
in YM (P 0.05). There were no differences between OM and
YM with respect to tendon deformation, stiffness, strain, stress,
or Young’s modulus based on average tendon CSA. Mechan-
ical properties at a common force are shown in Table 4. Again,
there were no differences between OM and YM for any of the
variables (Figs. 1 and 2).
Collagen concentration and cross-link density data are
shown in Table 5. Collagen concentration was lower in OM
than in YM (P  0.05). Both HP and LP (P  0.05) as well as
pentosidine (P  0.01) concentrations in collagen were higher
in OM than in YM. Pentosidine was positively related to age in
YM (r 0.74, P 0.01, Fig. 3) but not in OM (r 0.65, P
0.11). There were no significant correlations between the
mechanical and biochemical variables.
DISCUSSION
To the best of our knowledge, this is the first study that has
examined both the mechanical properties of the human patellar
tendon in vivo and collagen cross-link densities in YM and OM
with similar physical activity levels. The main findings were
that the collagen concentration was lower in OM than in
YM, whereas the enzymatically derived cross-links (HP and
LP) were greater in OM than in YM. At the same time, the
nonenzymatically derived AGE marker (pentosidine) was
markedly more abundant in OM than in YM. However, despite
these apparent age-related differences in the tendon collagen
properties, the tendon mechanical properties in the two age
groups did not diverge appreciably.
It is well known that age is associated with a loss in muscle
mass and consequently a reduction in muscle function (66). It
Fig. 1. The patellar tendon force-deformation relationship based on common
force. Values are means  SD of all subjects. There were no differences
between old (OM) and young men (YM) with respect to tendon deformation or
stiffness (P  0.05).
Table 3. Patellar tendon mechanical properties for OM and
YM based on maximum force
OM (n  7) YM (n  10)
Force, N 5,161737* 7,4152184
Deformation, mm 2.60.4 2.90.9
Stiffness, N/mm 3,9261091 5,5461871
Stress, MPa 518 6524
Strain, % 6.10.9 6.92.3
Modulus, GPa 1.70.3 2.20.7
Values are means  SD. *Significantly different from YM, P  0.05.
Table 2. Patellar tendon dimensions and quadriceps muscle
CSA for OM and YM
OM (n  7) YM (n  10)
Tendon length, mm 434 435
Tendon CSA, mm2 10117 1038
Tendon CSA, mm2/body wt2/3 5.340.48 5.470.25
Quadriceps muscle CSA, mm2 6,214705* 8,431522
Values are means  SD. CSA, cross-sectional area. *Significantly different
from YM, P  0.01.
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has also been suggested that tendon compliance and electro-
mechanical delay increase with aging (80), which would re-
duce efficient transfer of contractile force and therefore am-
plify the age-associated decline in muscle function. However,
to what extent the mechanical properties of human tendon
change with aging remains unclear. Data based on animal
models are disjointed as they suggest that aging reduces (27,
90, 91), augments (34, 69, 83), or leaves the mechanical
properties unchanged (39). Similarly, data based on human in
vivo models are inconclusive. These studies show that, with
aging, the tendon becomes more compliant (43, 52, 61, 63, 70),
less compliant (47–49), or remains unchanged (18, 43). In
contrast, data on isolated human cadaver preparations consis-
tently suggest that aging does not influence the mechanical
properties (31, 40, 41), which is in agreement with the present
data and that of Carroll et al. (18) on human patellar tendon in
vivo.
The present mechanical data diverge from those of others
based on the human in vivo model with one exception (18), and
this may be related to methodological differences and study
design. It has been shown that strength training and habitual
loading pattern may result in tendon hypertrophy (6, 21, 46),
which would influence the mechanical properties of the tendon
(80). In contrast to previous in vivo studies (18, 43, 47, 52, 61,
63, 70), we have taken this aspect into account by comparing
age groups with similar activity levels. However, it cannot be
ruled out that prior life-long training history, including exercise
mode and intensity, which was unaccounted for in the study,
may have influenced the data. Furthermore, it has been shown
that the ultrasonography-based method of obtaining patellar
tendon deformation requires that the movement of the tibia also
has to be considered (37, 71), which was achieved in the
present study and in the study by Carroll et al. (18). Notably,
the present data and that of Carroll et al. (18) cannot demon-
strate any age-associated difference in mechanical properties of
the patellar tendon. Moreover, several studies have investi-
gated the effect of aging on the mechanical properties based on
a composite measure of deformation that includes both that of
the tendon and aponeurosis, rather than the tendon per se (43,
52, 61, 63, 70). This makes direct comparisons of results
difficult since the free tendon and aponeurosis have dissimilar
mechanical properties and because the stiffness of the aponeu-
rosis can be modulated during contraction (30, 57). It should
also be recognized that the present data and that of others are
based on cross-sectional designs with inherent limitations,
including the striking variations in tendon mechanical proper-
ties between subjects (54); therefore, a type II error cannot be
ruled out.
The densities of mature lysyl oxidase-derived intermolecular
covalent cross-links, such as HP and LP, gradually increase
during tendon tissue maturation, and it is commonly believed
that these cross-links are the chief contributors to the function
and mechanical properties of the tendon (7, 9, 12, 76). In
animal models, it has been shown that there is a positive
Fig. 2. The patellar tendon stress-strain relationship based on common force.
Values are means SD of all subjects. There were no differences between OM
and YM with respect to tendon strain, stress, or Young’s modulus based on
average tendon cross-sectional area (P  0.05). Fig. 3. Pentosidine was positively related to age in YM (r  0.74, P  0.01).
Table 4. Patellar tendon mechanical properties for OM and
YM based on common force
OM (n  7) YM (n  10)
Deformation, mm 2.30.4 2.40.6
Stiffness, N/mm 3,511837 3,290869
Stress, MPa 417 375
Strain, % 5.30.9 5.91.7
Modulus, GPa 1.50.4 1.40.4
Values are means  SD.
Table 5. Concentration of collagen and hydroxylysyl
pyridinoline, lysyl pyridinoline, and pentosidine cross-links
in the patellar tendons of OM and YM
OM (n  7) YM (n  10)
Collagen, mg/mg dry wt 0.490.27* 0.730.14
Hydroxylysyl pyridinoline, mmol/mol collagen 898172* 645183
Lysyl pyridinoline, mmol/mol collagen 4938† 168
Pentosidine, mmol/mol collagen 7313† 112
Values are means  SD. *,†Significantly different from the values of YM
(P  0.05 and P  0.01, respectively).
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relationship between HP cross-link density and mechanical
strength of the healing medial collateral ligament tissue and
anterior cruciate ligament graft (32, 68) and furthermore that
changes in HP and LP density will result in altered mechanical
properties in collagenous tissue (7, 72). However, there are
only sparse human data on mature cross-link density in tendon
and how these are influenced by aging (11). A small but
significant age-related increase of LP has been demonstrated in
the supraspinatus tendon in vitro (11). The present data on LP
and HP densities of YM correspond well with previously
reported data in a similar population (45). However, the present
data also demonstrate that HP and LP densities of the human
patellar tendon were 40% and threefold higher, respectively,
in OM than in YM, suggesting a rather marked age-associated
elevation in these enzymatic cross-links. It is noteworthy that,
despite the rather robust difference in both HP and LP, there
was no difference in the mechanical properties of the tendon.
However, it should be noted that fibril length (22, 77), fibril
diameter (74), and proteoglycans and glycosaminoglycans (44,
73, 75) have all been implicated in contributing to the tendon
mechanical properties, and the relative contribution of these
factors and that of mature cross-links remains elusive.
To our knowledge, these are the first data showing that AGE
is markedly increased in the human patellar tendon of OM vs.
in that of YM. AGE cross-links, including pentosidine, are
formed when lysine amino acid residues in the collagen triple
helix come into contact with glucose (7, 62), and the accumu-
lation of these cross-links is known to accelerate with aging (7,
44) and disease processes such as diabetes (16, 28, 62),
atherosclerosis (88), Alzheimer (20, 64), and renal failure (89).
AGE products are also used as markers of tissue turnover (11).
It has been shown that the difference between young and older
individuals in AGE cross-link density in collagen is2-fold in
human skeletal muscle (38), 5-fold in human bone (81), 7-fold
in human tendon (present data), 9-fold in human ligaments
(19), and 33-fold in human cadaver cartilage (86), demonstrat-
ing the tissue-specific turnover. The fact that pentosidine den-
sity is sevenfold greater in tendon of OM than in YM (Table 5),
coupled with the fact that pentosidine appears to be related to
age in a narrow age span (Fig. 3), firmly demonstrates the
positive relationship between AGE cross-linking of human
patellar tendon collagen and aging ex vivo. These data corrob-
orate and extend those previously reported on cadaver tissue
(11, 84). From a functional standpoint, an elevated AGE
cross-link density has been suggested to result in increased
tensile stress and tendon stiffness in animal models (4, 5, 8, 34,
78, 79, 85). However, in the present study, both the stiffness
(Fig. 1) and the Young’s modulus (Fig. 2) of the tendon did not
differ between OM and YM despite the sevenfold difference in
pentosidine, suggesting that factors other than AGE may also
play a major role in determining the mechanical properties of
human tendon.
In the present study, the total collagen concentration of the
patellar tendon was 34% lower in OM than in YM (Table 5),
and this age-linked reduction is in accordance with that found
in the canine patellar tendon (39) and rat tail tendon (90). It is
possible that the lower collagen concentration with aging may
represent the reduced size and/or density of collagen fibrils that
is known to occur with aging (26, 65, 74, 76, 82). It was
recently reported that MRI signal intensity of the patellar
tendon was reduced with aging (18), which may be a function
of the reduction in collagen concentration observed in the
present study. Unfortunately, the size of the obtained biopsy in
the present study precluded transmission electron microscopy
analysis for fibril size and density. The lower collagen concen-
tration in OM may be an age-related change in the tendon per
se and/or a function of reduced tendon loading due to an
age-related loss of muscle mass/strength. Interestingly, the
average whole tendon CSA did not differ between OM and YM
(Table 2), which in light of the reduced collagen concentration
may be related to increased amounts of other extracellular
matrix components, such a proteoglycans and glycosaminogly-
cans. Alternatively, the retained tendon CSA in OM may result
from tendon intrafibrillar fat that can accumulate with aging (1,
2, 25). It has previously been demonstrated that the Achilles
tendon CSA is larger in postmenopausal women than in young
women (55), but it should be noted that female hormones may
significantly impact collagen synthesis (36, 56). This potential
sex-dependent factor is the reason that we have undertaken the
present study in men only.
Albeit speculative, it is possible that the elevated enzymatic
and/or nonenzymatic cross-link density in OM vs. that shown
in YM served to maintain tendon stiffness and Young’s mod-
ulus despite the diminished collagen concentration. Such main-
tenance of tendon stiffness would serve to maintain effective
transfer of muscle force despite a lower absolute muscle size
(Table 2) and strength (Table 3). In this context, it should be
noted that the present data were obtained in moderately phys-
ically active individuals, and future studies will need to address
the effect of training per se in elderly.
In conclusion, results from the present study raise the pos-
sibility that the dimensions and mechanical properties of the
human patellar tendon in vivo may not differ between OM and
YM. On the other hand, the OM group displayed lower
collagen concentration, but greater enzymatic (HP and LP) and
nonenzymatic (pentosidine) collagen cross-links, than YM.
This age-related increase in both enzymatic and nonenzymatic
cross-linking compounds may serve to maintain the mechani-
cal properties of tendon with aging.
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